Ampio Pharmaceuticals Inc... (AMPE)
0.00
-0.00 (-100.00%)
At close: Jan 15, 2025, 8:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -8.63M | -16.34M | -17.07M | -15.89M | -13.63M | 33.99M | -51.89M | -19.16M | -33.71M | -39.05M | -24.53M | -11.59M | -18.36M | -8.05M | -26.05K | -31.88K | -32.00K | -1.00K |
| Depreciation & Amortization | 122.00K | 1.05M | 1.09M | 1.18M | 1.27M | 1.28M | 1.21M | 1.21M | 1.14M | 439.10K | 137.68K | 62.40K | 42.55K | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 159.00K | 953.00K | 2.72M | 1.28M | 405.00K | 443.79K | 744.87K | 1.52M | 6.17M | 7.85M | 3.45M | 1.52M | 1.99M | 3.10M | n/a | n/a | n/a | n/a |
| Other Working Capital | -1.24M | 985.00K | -3,262.00B | 2,475.00B | -1.34M | -1.27M | -364.90K | 477.36K | -133.17K | -1.27M | 504.96K | -171.77K | -109.14K | 613.49K | n/a | -5.89K | 13.65K | n/a |
| Other Non-Cash Items | 1.02M | -3.82M | 80.00K | 624.00K | 80.00K | 60.00K | 483.24K | 240.44K | 443.59K | 240.41K | 88.05K | 100.15K | 1.56M | 1.33M | n/a | n/a | n/a | n/a |
| Deferred Income Tax | n/a | n/a | -3.49M | 72.00K | -4.87M | -45.18M | 36.33M | 2.10M | 78.04K | 28.68K | 516.84K | -205.77K | 5.59M | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -1.24M | -2.97M | 2.58M | -1.99M | 1.36M | -2.73M | 1.71M | -537.03K | -559.24K | -252.67K | 1.20M | 398.73K | 57.04K | 998.50K | 4.67K | -5.89K | 13.65K | 14.00 |
| Operating Cash Flow | -8.56M | -21.13M | -14.09M | -14.73M | -15.38M | -12.14M | -11.41M | -14.62M | -26.44M | -30.74M | -19.13M | -9.72M | -9.13M | -2.63M | -21.38K | -37.77K | -18.35K | -990 |
| Capital Expenditures | n/a | n/a | -97.00K | -63.00K | -22.00K | -564.28K | -72.33K | -6.84K | -235.66K | -8.67M | -1.64M | n/a | -84.70K | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.54M | -5.40K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -890 | 10.39K | -23.86K | 15.00K | -35.00K | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | -97.00K | -63.00K | -22.00K | -564.28K | -72.33K | -6.84K | -1.78M | -8.66M | -1.67M | 15.00K | -119.70K | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.17M | n/a | n/a | n/a | 282.00K | 2.01M | 200.00K | 38.96K | 20.00K | n/a |
| Common Stock Repurchased | n/a | -79 | -186.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -98.00K | -111.00K | -2.28M | -585.00K | 2.21M | 4.08M | 1.45M | -375.06K | -317.06K | -4.98M | -528.91K | -1.52M | -2.78M | -150.00K | 1.07M | n/a | -60 | 990.00 |
| Financial Cash Flow | n/a | -111 | 30.73M | 25.61M | 14.35K | 12.08K | 14.79M | 3.53M | 4.86M | 63.41M | 29.43M | 16.02M | 19.94M | 3.23M | 19.13K | 38.96K | 19.94K | 990.00 |
| Net Cash Flow | -8.56M | -21.24M | 16.55M | 10.81M | -1.05M | -623.68K | 3.31M | -11.10M | -23.36M | 24.01M | 8.63M | 6.32M | 10.69M | 599.30K | -2.25K | 1.19K | 1.59K | n/a |
| Free Cash Flow | -8.56M | -21.13M | -14.19M | -14.79M | -15.40M | -12.70M | -11.48M | -14.63M | -26.68M | -39.41M | -20.77M | -9.72M | -9.22M | -2.63M | -21.38K | -37.77K | -18.35K | -990 |